Skip to main content

Health condition

NMO spectrum disorder (NMOSD)

NMOSD is a rare autoimmune condition - distinct from MS - in which aquaporin-4 antibodies attack the optic nerves and spinal cord, causing severe attacks that demand rapid treatment and lifelong relapse prevention.

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against current NHS and UK specialist society guidance at the time of review.

  • 03

    Current for 2026

    Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.

Key facts

The essentials at a glance.

The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.

  • Severe optic neuritis and long spinal cord lesions are the hallmark attacks

  • Aquaporin-4 antibody blood testing is central to diagnosis

  • Attacks are treated urgently with steroids and plasma exchange; relapse prevention is lifelong

  • Specialist: NMOSD care is coordinated through specialist centres in the UK

Understanding the condition

What it is and what happens next.

What causes it, how it is diagnosed, and the treatment routes available in the UK.

What it is and how it feels

In NMOSD the immune system targets aquaporin-4, a water channel on the support cells of the central nervous system, producing attacks that are typically more severe than MS relapses: profound visual loss in one or both eyes, extensive myelitis with marked weakness and bladder involvement, or intractable hiccups and vomiting from brainstem involvement. Recovery from each attack is often incomplete, which is why prevention dominates management.

Diagnosis and treatment routes

Diagnosis combines the clinical syndrome, MRI showing long cord lesions, and serum aquaporin-4 antibody testing; distinguishing NMOSD from MS is critical because some MS drugs make NMOSD worse. Acute attacks receive high-dose steroids with early plasma exchange, and long-term prevention uses immunotherapies including newer targeted agents, delivered through the UK's commissioned specialist NMO services. In many parts of the UK, routine NHS referrals for this kind of problem currently take 20-45+ weeks, whereas an initial appointment with a private consultant is typically available within around two weeks.

Seeing a specialist

Who to see, and how quickly you can be seen.

The specialist for this condition is usually a consultant neurologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.

Frequently asked

Common questions about NMO spectrum disorder (NMOSD).

Quick, plain-English answers to what people ask us most.

  • What is NMO spectrum disorder (NMOSD)?

    Neuromyelitis optica spectrum disorder is a rare autoimmune condition causing inflammation and damage primarily to the optic nerves and spinal cord, historically confused with multiple sclerosis but now recognised as a distinct condition with different antibodies and treatment.

  • What causes NMOSD?

    Most cases are caused by antibodies against a protein called aquaporin-4, which is found in cells that support nerve tissue, particularly in the optic nerves and spinal cord, leading to targeted immune attack in these areas.

  • What are the symptoms of NMOSD?

    Symptoms include sudden vision loss from optic neuritis, often severe and affecting both eyes, and spinal cord attacks causing weakness, numbness, and bladder or bowel dysfunction, typically occurring as distinct relapses.

  • NMOSD versus multiple sclerosis: what's the difference?

    Both cause optic nerve and spinal cord inflammation, but NMOSD is caused by different antibodies, tends to cause more severe individual attacks, and requires different long-term treatment, making accurate diagnosis through specific antibody testing essential.

  • Is NMOSD dangerous?

    Yes, individual attacks can cause severe, sometimes permanent disability, including significant vision loss or paralysis, making prompt treatment of attacks and long-term prevention of relapses particularly important.

  • Can NMOSD be treated?

    Yes, acute attacks are treated with high-dose steroids and often plasma exchange, while several specific long-term immunosuppressive medications, including newer targeted biologic drugs, are now available to prevent future relapses.

  • When should I seek urgent care for suspected NMOSD, and how quickly can ongoing treatment be arranged privately?

    Seek emergency assessment for sudden vision loss or limb weakness, as prompt steroid treatment during an attack significantly affects recovery. Ongoing specialist neurology care and long-term treatment planning can typically be arranged privately within about two weeks.